Anti-neutrophil antibodies have been shown in sera from patients with a variety of inflammatory diseases. Those reacting with compo-
Anti-neutrophil cytoplasmic antibodies (ANCA) have been described in sera from patients with a variety of vasculitic syndromes.' Their presence has high diagnostic specificity for vasculitis, and in some patients correlates well with disease activity.2 Antigens recognised by ANCA are, by definition, in the cytoplasm and are present predominantly in the primary granules. Using a standard indirect immunofluorescent test we and others have found that ANCA give two distinct patterns on ethanol fixed human neutrophilseither a coarse, granular cytoplasmic staining (c-ANCA) or a perinuclear staining pattern (p-ANCA) which is the result of the redistribution of granule constituents after fixation. 3 Serum autoantibodies reacting with lymphocytes,4 colonic epithelial cells,'6 and hepatic portal tracts7 have been reported in patients with inflammatory bowel disease. Other studies have described the presence of anti-neutrophil antibodies showing either a nuclear'9 or perinuclear distribution'`in fixed neutrophils in patients with inflammatory bowel disease, a finding of particular interest in view of the proposal that Crohn's disease may represent a form of vasculitis affecting the gut." Autoimmune mechanisms are thought to be involved in both vasculitis and inflammatory bowel disease. Although clear associations exist between disease activity and ANCA titre in a number of patients with vasculitis, studies in inflammatory bowel disease have provided conflicting results.9 '°W e have examined sera from patients with inflammatory bowel disease for the presence of anti-neutrophil antibodies in an attempt to characterise their antigen specificity and relation to diagnosis, disease distribution and activity, and treatment.
Methods
Serum samples from patients with inflammatory bowel disease and three groups of control subjects were coded, aliquoted, and stored at -20°C until analysed blind for antibodies to human neutrophils or to neutrophil components.
INFLAMMATORY BOWEL DISEASE PATIENTS
Crohn's disease and ulcerative colitis were diagnosed by conventional clinical, radiological, endoscopic, and histological criteria.
Crohn's disease Fifty patients with Crohn's disease were studied. Their median age was 33 years (range 21-69) and 13 were men. The disease distribution of these patients is shown in Table II . Sixteen patients were taking oral corticosteroids, 20 sulphasalazine or a derivative, 4 topical steroids, 7 metronidazole, 5 azathioprine, and 17 were on no treatment (some patients were on more than one treatment). Activity of Crohn's disease was assessed using Harvey (4) , constipation (2) ).
Inflammatory disease hospital controls (group II)
This group comprised eight patients (age 29 (8-65) years, three men) attending hospital with bacterial diarrhoea (Shigella (2), Salmonella (2), Campylobacter (2)), pelvic inflammatory disease (1), and quiescent chronic active hepatitis (1)).
PREPARATION OF NEUTROPHILS
Human neutrophils were prepared from peripheral blood using standard techniques. 14 Briefly, blood from normal healthy volunteers was taken into heparinised containers. Neutrophils were separated by sedimentation with 1% dextran T500 (Pharmacia, Uppsala, Sweden) for 30 minutes at room temperature followed by centrifugation over Lympho-paque (Nygaard, Oslo, Norway). Red 10 minutes, the nuclear contents were discarded and the post nuclear supernatant retained. Post nuclear supernatant was fractionated by centrifugation (100 OOOg for 14 hours) on discontinuous sucrose gradients according to the method of Boregaard et al.`Fractions containing the different subcellular organelles were separated according to increasing density as follows: cytosol, plasma membranes, secondary granules, and primary granules. A primary granule extract was prepared by disrupting the granules by sonication in the presence of a proteolytic enzyme inhibitor (1 mmol/l DIFP).
The contents were extracted with acetic acid pH 4-5 and 0.5 mol/l NaCl.'6 This primary granule extract was subsequently used as substrate in ELISA tests. It was shown to contain serine protease 3 and elastase in a direct binding ELISA using monoclonal antibodies against serine protease 3 (Central Blood Transfusion Laboratory, Amsterdam; CLB-ANCA, clone number 12.8) and elastase (NP 57, Dako Laboratories). Myeloperoxidase was purified from primary granules according to the method of Mathieson et al. 17 The purity index (A430/A280) of myeloperoxidase prepared for these studies was 08. (Fig IA-C, Table III ). The predominant pattern was intense perinuclear staining around neutrophil nucleii (17/32; Fig  lA) . The nuclei of monocytes, lymphocytes, and other leukocyte nuclei were not stained. Staining was also noted to radiate into the cytoplasm of the neutrophils to varying extents with different sera and preparations, although the predominant staining pattern was highly reproducible when neutrophils from different donors were used. In contrast, known p-ANCA containing sera from patients with vasculitis gave clearly defined perinuclear staining.3 In addition, a homogeneous cytoplasmic staining was given by 12 sera from patients with inflammatory bowel disease. This was dense and non-granular (Fig 1B) with vasculitis, which is characteristically coarse, granular, and centrally accentuated. The third staining pattern seen was diffuse nuclear staining of all leukocyte nucleii (Fig IC) . In all cases this was shown to be due to the presence of antinuclear antibodies (ANA) in sera, the titre on HeP2 cells exceeding that of neutrophils by at least two doubling dilutions (Table III) . The titre of anti-neutrophil antibodies on ethanol fixed neutrophils by inflammatory bowel disease sera ranged from 1/20-1/1000 (Table II) . Half of those with low titres (positive at 1/20 dilution only) gave a diffuse cytoplasmic staining pattern (Table III) .
seen. Sixteen of the sera positive on both acetone and ethanol fixed neutrophils had given titres exceeding 1/50 on ethanol fixed cells. These results suggest that acetone fixation reduced the sensitivity of the test.
When cytospin preparations were prefixed in 2% formaldehyde in PBS and then in cold ethanol, 21/32 sera positive on cells fixed with ethanol alone sera lost their ability to bind to neutrophils (Table III) . ELISAS ANCA in sera from patients with vasculitis 60 -ANTI-NUCLEAR ANTIBODIES A total of six patients had detectable anti-nuclear antibodies on HeP2 cells. In three patients, the titre of anti-nuclear antibodies was at least twofold lower than that given by the same sera on ethanol fixed neutrophils, two of which gave a cytoplasmic pattern and one a perinuclear one. It was therefore likely that autoantibodies of at least two specificities were present in these sera.
EFFECT OF FIXATIVES ON STAINING PATTERNS
The choice of fixative for the measurement of leukocyte autoantibodies has been shown to influence both the distribution and frequency of staining.3 1 ' This is illustrated in Table III (Fig 2) . Although the inflammatory bowel disease sera gave significantly higher binding (p<0001, Mann-Whitney U test) than normal controls, only two sera from patients with ulcerative colitis (sera numbers 7 and 15 in Table III These autoantibodies were present in over 50% of sera from patients with ulcerative colitis but in only 10% taken from those with Crohn's disease.
Autoantibodies reacting with several different tissues have been reported in patients with inflammatory bowel disease.`Recently, circulating antibodies thought to react with portal tracts of obstructed human liver have been shown to be directed against the nuclei of neutrophils present in this tissue.9 These antibodies were termed ANNA (anti-neutrophil nuclear antibodies) by the authors who concluded that they may be analogous to granulocyte specific anti-nuclear antibodies (GS-ANA) described by others in sera from patients with rheumatoid arthritis, Felty's syndrome, and systemic lupus erythematosus.' The incidence of 'GS-ANA' in patients with inflammatory bowel disease has ranged from 0% in an unselected group of colitics20 to 98% of patients with recently active ulcerative colitis.9 However, in our and other studies using an indirect immunofluorescence technique, the neutrophil antigens recognised by inflammatory bowel disease sera seem to be cytoplasmic or perinuclear, not nuclear in distribution.''°This could reflect the different visualisation techniques used for detection of anti-neutrophil antibodies. In the study by Snook et al,9 an immunoperoxidase technique was employed. When either 3-3 diamino benzidine or 3 amino 9 ethylcarbazole are used as substrates in this test, detection of positive reactions are due to precipitation of insoluble colour products. With the indirect immunofluorescence technique, there is direct visualisation of antibody binding. Therefore, although increased sensitivity through amplification of a positive signal is an advantage of using the immunoperoxidase technique, distortion of the intracellular location of an antigen is more likely to be a problem.
A cytoplasmic location for anti-neutrophil antibody binding was also suggested by the significantly higher binding of indirect immunofluorescence positive inflammatory bowel disease sera to neutrophil primary granules in an ELISA, compared with normal controls. However, only two sera gave a strongly positive reaction. This suggests that the antigens recognised by anti-neutrophil antibodies in inflammatory bowel disease are either not present in high enough concentrations in the primary granule extract 4 Although all sera used in our study were centrifuged before use, immune complex binding to Fc receptors on neutrophils may explain some of the weakly positive staining of neutrophil cytoplasm reported here. None of the inflammatory bowel disease sera reacted with serine protease 3, the antigen recognised by most c-ANCA positive sera from patients with vasculitis. '4 The predominant pattern of neutrophil staining by inflammatory bowel disease sera in our studies was, however, perinuclear. The peri-nuclear pattern seen could be due to leakage of nuclear antigens into the cytoplasm'9 or a cytoplasmic component associating with the nucleus.' In patients with vasculitis, the p-ANCA staining pattern is usually attributable to the presence of antibodies to myeloperoxidase, although antibodies to other primary granule constituents such as elastase, lactoferrin, and cathepsin G can give similar patterns on ethanol fixed neutrophils. 25 We did not find antibodies to myeloperoxidase or elastase in inflammatory bowel disease era. Antibodies to cathepsin G and elastase were also reportedly absent from inflammatory bowel disease sera in another recent study.2' Serum antibodies to myeloperoxidase were found in 1 of 20 patients with ulcerative colitis and Crohn's disease'°and Duerr et a12' claimed (data not shown) that sera from a subset of patients with ulcerative colitis and primary sclerosing cholangitis giving a perinuclear staining pattern by indirect immunofluorescence were associated with the presence of antimyeloperoxidase antibodies. However, the antigens responsible for most of the perinuclear staining pattern shown by inflammatory bowel disease sera do not seem to be those recognised by p-ANCA in vasculitis.
A diffuse, nuclear staining pattern of ethanol fixed neutrophils by inflammatory bowel disease sera was also seen. In most cases this was due to the presence of anti-nuclear antibodies present in the sera, as detected by positive staining of HeP2 cell nuclei. Anti-nuclear antibodies have previously been shown to give variable staining patterns of human granulocytes. " In patients with vasculitis, formalin fixation does not alter binding of ANCA to neutrophils, merely preventing the redistribution of some primary granule components to the perinuclear site.3 Saxon et al'°claimed that fixation with paraformaldehyde, glutaraldehyde, and methanol did not change the staining pattern of inflammatory bowel disease sera on human neutrophils. In contrast, our studies showed that paraformaldehyde fixation ablated the reactivity of 60% of inflammatory bowel disease sera with human neutrophils. This could be due to destruction of antigenic epitopes by formaldehyde or, as discussed by Wiik,"' the loss of low molecular weight autoantigens highly soluble in PBS from the cell when exposed to fixatives in saline solutions. Alternatively, the disparity between our results and those previously reported'0 could simply reflect methodological differences such as length of exposure to, or pH of, the paraformaldehyde used as fixative.
The subclass of anti-neutrophil antibodies measured in this and most other studies has been
IgG.'02' Snook et al' reported that IgM and IgG ANNA were also present in inflammatory bowel disease sera although the dominant subclass was IgG. We also detected IgM and IgA antineutrophil antibodies in inflammatory bowel disease sera, although they were of low titre and present only when high titre IgG antibodies were also present (data not shown). In Crohn's disease, the low prevalence of antineutrophil antibodies makes the test unlikely to be of value as a diagnostic marker. However, the relatively high prevalence in ulcerative colitis suggests that the test may be of some use in differentiating this condition from Crohn's colitis, localised proctitis, and other causes of diarrhoea. There was no association between the presence of circulating antibodies to human neutrophils in inflammatory bowel disease patients and disease activity or drug treatment. Saxon et al'°concluded that anti-neutrophil antibodies in Crohn's disease occurred only in patients with disease affecting the colon. In contrast, we found such antibodies in two patients with Crohn's disease apparently confined to the small bowel and in only one subject with Crohn's colitis.
In conclusion, most inflammatory bowel disease sera that react with ethanol fixed human neutrophils give a perinuclear or clearly cytoplasmic staining pattern. Although ANCA assume similar staining patterns, the antibodies being directed against constituents of neutrophil primary granules, it is unclear whether the neutrophil antigens recognised by inflammatory bowel disease sera are nuclear or cytoplasmic in distribution. The staining patterns described by us and others could equally be interpreted as leakage of soluble antigens from the nucleus. More sensitive techniques are required to determine the location and identity of inflammatory bowel disease associated anti-neutrophil antigens. 
